Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study

被引:6
|
作者
Park, Joo-Hyun [1 ]
Song, Yun-Mi [2 ]
Jung, Jin-Hyung [3 ]
Han, Kyungdo [4 ]
机构
[1] Korea Univ, Coll Med, Dept Family Med, Ansan Hosp, Ansan, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Dept Family Med, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
[3] Catholic Univ, Dept Biostat, Coll Med, Seoul, South Korea
[4] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
关键词
Fractures; Gastroesophageal reflux; Histamine-2 receptor antagonist; Osteoporosis; Proton pump inhibitor; BONE-MINERAL DENSITY; HIP FRACTURE; VITAMIN-B-12; OMEPRAZOLE; MEDICATIONS; ABSORPTION; SECRETION; INCREASE; HEALTH; DRUGS;
D O I
10.1016/j.bone.2020.115306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The influence of proton pump inhibitors (PPIs) on the risk of osteoporotic fractures remains to be elucidated, especially in the Asian population. This study evaluated the risk of osteoporotic fractures in elderly female Korean PPI users compared to histamine-2 receptor antagonist (H2RA) users, as well as the relationship between fractures and the duration, dose, and pattern of use of PPI. We screened a nationwide cohort of elderly Korean women who underwent bone mineral density measurements during their 66-year-old life-transition medical examination between 2009 and 2014. Study subjects included 8903 cases diagnosed with new osteoporotic fractures and 44,515 matched controls (1:5 ratio based on cohort entry date, follow-up duration, and baseline osteoporosis status) without fractures. They were followed up until 2015. Information on the exposure to PPI or H2RA, occurrence of fracture, and covariates were obtained from the Korean National Health Insurance Service data. Covariate-adjusted odds ratio (aOR) and 95% confidence interval (CI) were estimated using conditional logistic regression analysis. PPI use was associated with an increased risk of osteoporotic fractures (aOR: 1.13, 95% CI: 1.07, 1.18) compared with H2RA-only use. Increasing duration of PPI use was positively associated with the risk of osteoporotic fracture [aOR (95% CI) of long-term PPI use (>= 1 year): 1.3 (1.09, 1.56)]. Recent PPI use within the last year was associated with an increased risk of fracture (aOR: 1.31, 95% CI: 1.23, 1.38), whereas remote PPI use was not (aOR: 0.98, 95% CI: 0.92, 1.04). The risk of fracture did not increase with the increasing cumulative PPI dose. Compared with the use of H2RA alone, PPI use was associated with an increased risk of osteoporotic fractures in elderly Korean women, particularly among those who had used PPI within the last year or for more than one year.
引用
收藏
页数:9
相关论文
共 45 条
  • [41] Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan
    Liao, Kuan-Fu
    Lin, Cheng-Li
    Lai, Shih-Wei
    Chen, Wen-Chi
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 27 : 76 - 79
  • [42] Reduction of Upper Gastrointestinal Bleeding Risk With Proton Pump Inhibitor Therapy in Asian Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulant: A Nationwide Population-based Cohort Study
    Lee, So-Ryoung
    Ahn, Hyo-Jeong
    Choi, Eue-Keun
    Park, Sang-Hyun
    Han, Kyung-Do
    Oh, Seil
    Lip, Gregory
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (05) : 981 - 993
  • [43] A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
    Lin, Wen-Ling
    Hsieh, Yow-Wen
    Lin, Cheng-Li
    Sung, Fung-Chang
    Wu, Chieh-Hsi
    Kao, Chia-Hung
    CLINICAL ENDOCRINOLOGY, 2015, 82 (04) : 503 - 508
  • [44] Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study' by Gong and Zhang and Lin et al
    Abtahi, Shahab
    Driessen, Johanna H. M.
    Burden, Andrea M.
    Souverein, Patrick C.
    van den Bergh, Joop P.
    Boonen, Annelies
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E143 - +
  • [45] Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case-Control Study Using a Korean National Health Screening Cohort
    Choi, Hyo Geun
    Lee, Hong Kyu
    Kang, Ho Suk
    Lim, Hyun
    Kim, Joo-Hee
    Kim, Ji Hee
    Kim, Nan Young
    Cho, Seong-Jin
    Nam, Eun Sook
    Min, Kyueng-Whan
    Kwon, Mi Jung
    PHARMACEUTICALS, 2022, 15 (05)